Strategic Realignment for a Better Future
Published: | Updated:
In adjusting to the long-term side-effects of the coronavirus pandemic, pharma companies will need to focus on change in three areas. Ben van der Schaaf and Aurelien Guichard report.
Ben van der Schaaf and Aurelien Guichard
Advertisement
Ben van der Schaaf is Partner and Aurelien Guichard is Manager and US Lead for Energy & Utilities, both at Arthur D. Little.
Articles by Ben van der Schaaf and Aurelien Guichard
Advertisement
Latest Updated Articles
Strategic Realignment for a Better FuturePublished: July 21st 2020 | Updated: November 15th 2020
Advertisement
Advertisement
Trending on PharmExec
1
uniQure and FDA Clash Over Regulatory Decision for Huntington’s Disease Therapy: Report
2
Advancing Full-Spectrum Cannabis Through FDA
3
AI's Inflection Point: Bridging the Adoption and ROI Gap
4
FDA Approves Johnson & Johnson’s Tecvayli as Second Line Treatment for RRMM
5